Healthcare professionals use the drug Bortezomib in treating patients who have multiple myeloma and mantle cell lymphoma. Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of the 26S proteasome in cells of mammals. The 26S proteasome is a large protein complex that degrades ubiquitinated proteins. The drug Bortezomib single-vial comes in 2 mg for subcutaneous and intravenous infusion. The active ingredient in the vials is Bortezomib, with the inactive ingredient mannitol. Bortezomib is a modified dipeptidyl boronic acid. The product is provided as a mannitol boronic ester which, in reconstituted form, consists of the mannitol ester in equilibrium with its hydrolysis product, the monomeric boronic acid. The drug substance exists in its cyclic anhydride form as a trimeric boroxine.
Bortezomib cost is reasonable, and it is readily available from several generic medicine suppliers in India. For more information, please ring us on 18008891064.